...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin’s lymphoma: in combination with the International Prognostic Index
【24h】

Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin’s lymphoma: in combination with the International Prognostic Index

机译:血清可溶性白介素2受体(sIL-2R)水平决定了侵袭性非霍奇金淋巴瘤患者的临床结局:结合国际预后指数

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to assess the prognostic significance of serum soluble interleukin-2 receptor (sIL-2R) in aggressive non-Hodgkin’s lymphoma (NHL).
机译:本研究的目的是评估血清可溶性白介素2受体(sIL-2R)在侵袭性非霍奇金淋巴瘤(NHL)中的预后意义。

著录项

  • 来源
  • 作者单位

    First Department of Internal Medicine Gifu University Graduate School of MedicineFirst Department of Internal Medicine Gifu University Graduate School of Medicine;

    First Department of Internal Medicine Gifu University Graduate School of Medicine;

    Department of Clinical Laboratory Gifu University Graduate School of Medicine;

    First Department of Internal Medicine Gifu University Graduate School of Medicine;

    First Department of Internal Medicine Gifu University Graduate School of Medicine;

    First Department of Internal Medicine Gifu University Graduate School of Medicine;

    First Department of Internal Medicine Gifu University Graduate School of Medicine;

    First Department of Internal Medicine Gifu University Graduate School of Medicine;

    First Department of Internal Medicine Gifu University Graduate School of Medicine;

    First Department of Internal Medicine Gifu University Graduate School of MedicineFirst Department of Internal Medicine Gifu University Graduate School of Medicine;

    First Department of Internal Medicine Gifu University Graduate School of Medicine;

    Department of Cellular Pathology Gifu University Graduate School of Medicine;

    Department of Clinical Laboratory Gifu University Graduate School of Medicine;

    First Department of Internal Medicine Gifu University Graduate School of Medicine;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Soluble interleukin-2 receptor (sIL-2R); International Prognostic Index (IPI); Prognostic factor; Non-Hodgkin’s lymphoma;

    机译:可溶性白介素2受体(sIL-2R);国际预后指数(IPI);预后因素;非霍奇金淋巴瘤;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号